Discover

NXTS
Nexentis Technologies Inc.
1.89
1 x 1.83
2 x 1.89
bid
ask
+
0.01
0.53%
1 @ 04:00 PM
1.89 +0.00 (0.00%)
Ytd-83.93%
1y-96.76%
1.80
day range
1.92
1.43
52 week range
59.78
Open1.92Prev Close1.88Low1.80High1.92Mkt Cap106.97K
Vol17.49KAvg Vol1.32MEPS-41.16P/E-0.05Forward P/EN/A
Beta1.83Short RatioN/AInst. OwnN/ADividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d Avg3.87200-d Avg9.271yr Est0.00

NXTS News

benzinga.com
Nexentis Technologies Subsidiary MitoCareX Bio Narrows Its SLC Transport Protein Candidates To Selec

As previously disclosed, MitoCareX's broad structural analysis identified a set of SLC transport

Nexentis Technologies Subsidiary MitoCareX Bio Selects Transport Protein Candidate for Drug Discovery Campaign
globenewswire.com
Nexentis Technologies Subsidiary MitoCareX Bio Selects Transport Protein Candidate for Drug Discover

Following its broad structural analysis of the human SLC transport protein family, MitoCareX advance

Nexentis Subsidiary MitoCareX Bio Advances SLC Transporter Drug Discovery with Broad Analysis and International AI Initiative
globenewswire.com
Nexentis Subsidiary MitoCareX Bio Advances SLC Transporter Drug Discovery with Broad Analysis and In

MitoCareX Bio completes comprehensive SLC transport protein analysis to support discovery of small m

Nexentis Announces Monetization of Part of its Melz Solar Investment at $14.5 Million Project Valuation – Significant Premium to Initial Investment
globenewswire.com
Nexentis Announces Monetization of Part of its Melz Solar Investment at $14.5 Million Project Valuat

Neve Yarak, Israel, June 29, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (NASDAQ: NXTS) (“Ne

Crude Oil Falls Over 2%; Getty Images Shares Spike Higher
benzinga.com
Crude Oil Falls Over 2%; Getty Images Shares Spike Higher

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling more than 300 poi

Nexentis Technologies Announces International AI Drug Discovery Initiative Between MitoCareX Bio and Boltz to Accelerate Novel SLC Small-Molecule Discovery
globenewswire.com
Nexentis Technologies Announces International AI Drug Discovery Initiative Between MitoCareX Bio and

MITOLINE ® -Enabled 3D Structural Modeling and Boltz AI Capabilities to Be Combined by MitoCareX in

Nexentis: Subsidiary MitoCareX Bio Successfully Completed Broad Analysis of SLC Transport Proteins to Support Discovery of Hard-to-Treat Cancers and Metabolic Diseases
globenewswire.com
Nexentis: Subsidiary MitoCareX Bio Successfully Completed Broad Analysis of SLC Transport Proteins t

Ness Ziona, Israel, June 17, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (NASDAQ: NXTS) ("Ne

Why La-Z-Boy Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why La-Z-Boy Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket

Shares of La-Z-Boy Inc (NYSE: LZB) rose 19.6% in pre-market trading after reporting better-than-expe

Why High Tide Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why High Tide Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket

HITI rose sharply in pre-market trading on strong Q2 results and continued to rise after market open

Nexentis Announces MitoCareX Bio Achieves Key R&D Milestone, Generating a Substantially Improved Hit Molecule on the Path to Pre-Clinical Development
globenewswire.com
Nexentis Announces MitoCareX Bio Achieves Key R&D Milestone, Generating a Substantially Improved Hit

Ness Ziona, Israel, May 18, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (NASDAQ: NXTS) ("Nex

Nexentis Technologies Announces Optimization of Hit Molecule at MitoCareX Bio Representing Key Drug Discovery Milestone
globenewswire.com
Nexentis Technologies Announces Optimization of Hit Molecule at MitoCareX Bio Representing Key Drug

MITOLINE-Powered Platform Delivers Optimized Hit Molecule, Strengthening the Foundation for Future P

Nexentis Technologies Announces U.S. Trademark Registration Approval for MitoCareX’s Algorithm Platform MITOLINE™
globenewswire.com
Nexentis Technologies Announces U.S. Trademark Registration Approval for MitoCareX’s Algorithm Platf

Neve Yarak, Israel, May 05, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (NASDAQ: NXTS), ("Ne

Contrasting Nexentis Technologies (NASDAQ:NXTS) & Scheid Vineyards (OTCMKTS:SVIN)
defenseworld.net
Contrasting Nexentis Technologies (NASDAQ:NXTS) & Scheid Vineyards (OTCMKTS:SVIN)

Nexentis Technologies (NASDAQ: NXTS - Get Free Report) and Scheid Vineyards (OTCMKTS:SVIN - Get Free

Nexentis Technologies Inc. Launches New Corporate Website, Showcasing Innovative AI-Driven Biotech Platform
globenewswire.com
Nexentis Technologies Inc. Launches New Corporate Website, Showcasing Innovative AI-Driven Biotech P

Visit Nexentis at: www. nexentistech. com Neve Yarak, Israel, March 13, 2026 (GLOBE NEWSWIRE) -- Nex